tiprankstipranks
Trending News
More News >
Medexus Pharmaceuticals Inc (TSE:MDP)
TSX:MDP
Canadian Market

Medexus Pharmaceuticals Inc (MDP) Income Statement

Compare
66 Followers

Medexus Pharmaceuticals Inc Income Statement

Last quarter (Q2 2026), Medexus Pharmaceuticals Inc's total revenue was $24.74M, a decrease of -5.94% from the same quarter last year. In Q2, Medexus Pharmaceuticals Inc's net income was $-315.00K. See Medexus Pharmaceuticals Inc’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 108.33M$ 113.05M$ 108.10M$ 76.70M$ 79.66M
Gross Profit
$ 56.58M$ 59.51M$ 60.04M$ 37.93M$ 42.01M
Operating Expenses
$ 48.36M$ 48.72M$ 52.42M$ 52.92M$ 41.27M
Depreciation and Amortization
$ 7.18M$ 5.81M$ 8.05M$ 7.40M$ 7.90M
EBITDA
$ 16.81M$ 19.28M$ 16.14M$ 15.16M$ -23.61M
Operating Income
$ 8.22M$ 10.79M$ 7.61M$ -15.00M$ -1.38M
Other Income/Expenses
$ -6.78M$ -10.69M$ -12.65M$ 11.18M$ -30.13M
Pretax Income
$ 1.44M$ 106.00K$ -5.04M$ -3.82M$ -31.50M
Net Income
$ 2.25M$ -214.00K$ 1.22M$ -2.88M$ -28.26M
Per Share Metrics
Basic EPS
$ 0.09$ -0.01$ 0.08$ -0.19$ -2.34
Diluted EPS
$ 0.08$ -0.01$ 0.08$ -0.19$ -2.34
Weighted Average Shares Outstanding
25.82M 22.32M 19.98M 19.45M 15.20M
Weighted Average Shares Outstanding (Diluted)
26.51M 22.49M 20.52M 19.86M 15.20M
Currency in USD

Medexus Pharmaceuticals Inc Earnings and Revenue History